
Relidoce 20mg Injection
Marketer
Reliance Formulation Pvt Ltd
Salt Composition
Docetaxel (20mg)
Overview Relidoce 20mg Injection
Oncaspar 20mg Injection, an anti-neoplastic agent, treats breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include dyspnea, constipation, edema, infections, anorexia, myalgia, nail abnormalities, pain, and fatigue. Supportive medications may mitigate these; however, report unexplained bleeding or bruising, pharyngitis, oral ulcers, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are essential throughout treatment. Prior to initiating therapy, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications, as drug interactions are possible. This medication is contraindicated in pregnancy and lactation; reliable contraception for both partners is mandatory during treatment.
Uses of Relidoce 20mg Injection
Cancers affecting the breast, lung (non-small cell), prostate, and head/neck regions.
Major Benefits of Relidoce 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relidoce 20mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Relidoce 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Relidoce 20mg Injection works:
Oncaspar 20mg Injection is a drug used in cancer treatment. Its mechanism of action involves disrupting microtubule networks, essential for cancer cell division and proliferation. This inhibits tumor growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Relidoce 20mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Relidoce 20mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Relidoce 20mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
Relidoce 20mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Relidoce 20mg Injection presents a safe treatment option. No alteration of the Relidoce 20mg Injection dosage is necessary.
LiverCAUTION
Individuals with hepatic impairment should use Relidoce 20mg Injection cautiously. Dosage modification of Relidoce 20mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Relidoce 20mg Injection :
NA
Facts to Know About Relidoce 20mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Taxanes: Antimicrotubule Agents |
